- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01040390
Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris
February 15, 2012 updated by: Dr. Anjali Miglani, Miglani, Anjali
Efficacy of Lesser Known Homoeopathic Medicines in Acne Vulgaris - Lappa Arctium
Acne is one of the most common skin problems in teenagers and adolescents.
There are many lesser known homoeopathic medicines which have been mentioned in the literature for treatment of acne but their potential has not been properly assessed /documented and therefore these medicines don't form a part of many prescriptions.
As a part of this study,efficacy of Lappa Arctium will be studied in the treatment of Acne vulgaris
Study Overview
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110075
- Delhi Government Health Centre - Homoeopathic Dispensary - Sector 12, Dwarka
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and females between 12 to 25 years of age
- Presence of inflammatory and non-inflammatory lesions
- Able to follow-up according to protocol
- Patients not taking any medication for treatment of Acne in preceding one month.
Exclusion Criteria:
- Acne Conglobata
- Pregnant or Breast feeding females or females having intention of becoming pregnant
- Significant systemic disease
- Any drug/ alcohol addiction
- History of chronic diseases treated with medications in the preceding month which might affect acne condition and treatment outcome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
percent change in acne lesion counts from the Baseline
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change in quality of life of subjects
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
December 26, 2009
First Submitted That Met QC Criteria
December 26, 2009
First Posted (Estimate)
December 29, 2009
Study Record Updates
Last Update Posted (Estimate)
February 17, 2012
Last Update Submitted That Met QC Criteria
February 15, 2012
Last Verified
February 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Acne-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acne Vulgaris
-
Ghurki Trust and Teaching HospitalCompletedAcne Vulgaris | Acne Vulgaris on the FacePakistan
-
Galderma R&DCompletedSevere Acne VulgarisUnited States, Canada, Puerto Rico
-
Sebacia, Inc.CompletedInflammatory Acne VulgarisUnited States
-
Nexgen Dermatologics, Inc.Unknown
-
Rejuva Medical AestheticsHealMD, LLCNot yet recruitingAcne Vulgaris (Disorder)United States
-
InMode MD Ltd.RecruitingInflammatory Acne VulgarisUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.Active, not recruitingModerate to Severe Acne VulgarisUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Bispebjerg HospitalCompleted
Clinical Trials on Lappa Arctium
-
OMNIFARMA LLCRecruitingHyperuricemia or GoutUkraine